Oncolytics Biotech Inc. - Common Stock — Financial Statements (NASDAQ:ONCY) | MetaTrader

Open full chart

News

Oncolytics Could Re-Rate As Pelareorep Focuses On Registrational Paths (NASDAQ:ONCY)

Oncolytics launches phase 2 colorectal cancer study REO 033

Oncolytics to wind down GOBLET study, focus on U.S. registration

Oncolytics Biotech stock soars after FDA grants Fast Track Designation

Pelareorep-atezolizumab shows promising results in anal cancer

Oncolytics Biotech plans to shift incorporation from Canada to Nevada

Oncolytics Biotech files patent application to extend pelareorep protection

Oncolytics Biotech expands GI cancer advisory board with three experts

Oncolytics reports 33% response rate in hard-to-treat colorectal cancer

Oncolytics Biotech reschedules shareholder vote on U.S. domicile move

Oncolytics Biotech (ONCY) Loses 8.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Oncolytics Biotech reschedules special meeting due to government shutdown